公开(公告)号：US20050209223A1

公开(公告)日：2005-09-22

申请号：US11120617

申请日：2005-05-03

申请人： Jagattaran Das ,  Selavakumar Natesan ,  Sanjay Trehan ,  Javed Iqbal ,  Sitaram Magadi ,  Naga Venkata Srinivasa Rao Mamidi ,  Rajagopalan Ramanujam

发明人： Jagattaran Das ,  Selavakumar Natesan ,  Sanjay Trehan ,  Javed Iqbal ,  Sitaram Magadi ,  Naga Venkata Srinivasa Rao Mamidi ,  Rajagopalan Ramanujam

IPC分类号： A61K31/4192 ,  A61K31/454 ,  A61K31/496 ,  A61K31/5355 ,  A61K31/5377 ,  A61K31/541 ,  A61K31/655 ,  A61P31/00 ,  A61P31/04 ,  C07D249/06 ,  C07D295/12 ,  C07D295/135 ,  C07D401/06 ,  C07D401/10 ,  C07D401/12 ,  C07D403/12 ,  C07D405/10 ,  C07D413/02 ,  C07D413/14 ,  C07D417/02 ,  C07D417/10 ,  C07D417/14

CPC分类号： C07D249/06 ,  C07D295/135 ,  C07D401/06 ,  C07D401/10 ,  C07D401/12 ,  C07D403/06 ,  C07D403/12 ,  C07D491/10

摘要： The present invention relates to novel triazole compounds of formula (I), their derivatives, their analogs, their tautomeric forms, their regioisomers, their rotamers, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutical compositions containing them. More particularly, the present invention relates to novel triazoles of the general formula (I) their derivatives, their analogs, their tautomeric forms, their regioisomers, their rotamers, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutical compositions containing them.

摘要翻译： 本发明涉及式（I）的新型三唑化合物，其衍生物，其类似物，其互变异构形式，其区域异构体，其旋转异构体，其立体异构体，其多晶型物，其药学上可接受的盐，其药学上可接受的溶剂合物和含有它们的药物组合物 。 更具体地，本发明涉及通式（I）的新型三唑衍生物，其类似物，其互变异构体，其区域异构体，其旋转异构体，其立体异构体，其多晶型物，其药学上可接受的盐，其药学上可接受的溶剂化物和药物 含有它们的组合物。

公开(公告)号：US06914058B2

公开(公告)日：2005-07-05

申请号：US10342114

申请日：2003-01-14

申请人： Jagattaran Das ,  Selavakumar Natesan ,  Sanjay Trehan ,  Javed Iqbal ,  Sitaram Kumar Magadi ,  Naga Venkata Srinivasa Rao Mamidi ,  Rajagopalan Ramanujam

发明人： Jagattaran Das ,  Selavakumar Natesan ,  Sanjay Trehan ,  Javed Iqbal ,  Sitaram Kumar Magadi ,  Naga Venkata Srinivasa Rao Mamidi ,  Rajagopalan Ramanujam

IPC分类号： A61K31/4192 ,  A61K31/454 ,  A61K31/496 ,  A61K31/5355 ,  A61K31/5377 ,  A61K31/541 ,  A61K31/655 ,  A61P31/00 ,  A61P31/04 ,  C07D249/06 ,  C07D295/12 ,  C07D295/135 ,  C07D401/06 ,  C07D401/10 ,  C07D401/12 ,  C07D403/12 ,  C07D405/10 ,  C07D413/02 ,  C07D413/14 ,  C07D417/02 ,  C07D417/10 ,  C07D417/14

CPC分类号： C07D249/06 ,  C07D295/135 ,  C07D401/06 ,  C07D401/10 ,  C07D401/12 ,  C07D403/06 ,  C07D403/12 ,  C07D491/10

摘要： The present invention relates to novel triazole compounds of formula (I), their derivatives, their analogs, their tautomeric forms, their regioisomers, their rotammers, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutical compositions containing them. More particularly, the present invention relates to novel triazoles of the general formula (I) their derivatives, their analogs, their tautomeric forms, their regioisomers, their rotamers, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutical compositions containing them.

摘要翻译： 本发明涉及式（I）的新型三唑化合物，其衍生物，其类似物，其互变异构形式，其区域异构体，其旋转异构体，其立体异构体，其多晶型物，其药学上可接受的盐，其药学上可接受的溶剂合物和含有它们的药物组合物 。 更具体地，本发明涉及通式（I）的新型三唑衍生物，其类似物，其互变异构体，其区域异构体，其旋转异构体，其立体异构体，其多晶型物，其药学上可接受的盐，其药学上可接受的溶剂化物和药物 含有它们的组合物。

公开(公告)号：US07202254B2

公开(公告)日：2007-04-10

申请号：US11120617

申请日：2005-05-03

申请人： Jagattaran Das ,  Selavakumar Natesan ,  Sanjay Trehan ,  Javed Iqbal ,  Sitaram Kumar Magadi ,  Naga Venkata Srinivasa Rao Mamidi ,  Rajagopalan Ramanujam

发明人： Jagattaran Das ,  Selavakumar Natesan ,  Sanjay Trehan ,  Javed Iqbal ,  Sitaram Kumar Magadi ,  Naga Venkata Srinivasa Rao Mamidi ,  Rajagopalan Ramanujam

IPC分类号： C07D401/10 ,  C07D401/14 ,  A61K31/4439 ,  A61P31/04

CPC分类号： C07D249/06 ,  C07D295/135 ,  C07D401/06 ,  C07D401/10 ,  C07D401/12 ,  C07D403/06 ,  C07D403/12 ,  C07D491/10

摘要： The present invention relates to novel triazole compounds of formula (I), their derivatives, their analogs, their tautomeric forms, their regioisomers, their rotamers, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutical compositions containing them. More particularly, the present invention relates to novel triazoles of the general formula (I) their derivatives, their analogs, their tautomeric forms, their regioisomers, their rotamers, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutical compositions containing them.

摘要翻译： 本发明涉及式（I）的新型三唑化合物，其衍生物，其类似物，其互变异构形式，其区域异构体，其旋转异构体，其立体异构体，其多晶型物，其药学上可接受的盐，其药学上可接受的溶剂合物和含有它们的药物组合物 。 更具体地说，本发明涉及通式（I）的新型三唑，